Our results showed high dose of CC1007-induced apoptosis in Nalm-6 and MHH-CALL-2 cells and primary CD34+ BCR-ABL1− pre-B-ALL cells (Fig. 2a and Supplementary Fig. 3). This evidence concerns the gene CHL1 and acute lymphoblastic leukemia.